Background Upper tract urothelial carcinoma (UTUC) is a rare and heterogeneous disease.
Several clinical and biological prognostic factors have been identified in multi-institutional …

Introduction The conservative management of upper tract urothelial carcinoma (UTUC) has
historically been offered to patients with imperative indications. The recent International …

Purpose There is limited evidence to support the use of adjuvant chemotherapy (AC) after
radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Against this …

Purpose To investigate the feasibility of using CT texture analysis (CTTA) to differentiate
between low-versus high-grade urothelial carcinoma. Methods A total of 105 patients with …

Immunohistochemistry of a transcription factor, GATA3, has been widely used as a
promising urothelial marker in diagnostic surgical pathology practice. However, the …

Purpose: We evaluated differences in clinicopathological characteristics and oncologic
outcomes between patients with upper tract urothelial carcinoma in mainland China and the …

Objective The purpose of this study was to investigate the correlation between the
controlling nutritional status (CONUT) score and survival of patients with localized urothelial …

Introduction To evaluate temporal trends in the delivery and extent of lymphadenectomy
(LND) in radical nephroureterectomy (RNU) performed in upper tract urothelial carcinoma …

Purpose: We developed a prognostic nomogram for patients with high grade urothelial
carcinoma of the upper urinary tract after extirpative surgery. Materials and Methods: Clinical …

Immunotherapy targeting the programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1)
pathway has shown promising results in several malignancies. However, the prognostic …